19 December 2022Cannasouth enters prospective merger arrangement with EqalisCannasouth Limited (NZX:CBD) is pleased to announce that it has signed a binding term sheet (“Term Sheet”) with the Board of ...Read More
14 December 2022Helius first to gain THC certification in NZHelius Therapeutics will soon launch THC containing medicines that are both grown and made in New Zealand. Read more ...Read More
7 December 2022Helius achieves GACP CertificationHelius Therapeutics has received Good Agricultural and Collection Practice (GACP) certification at its purpose-built medicinal cannabis facility in East Tamaki, Auckland. ...Read More
3 December 2022Helius gains NZ’s first GMP certification for cannabis medicinesNew Zealand’s largest licenced medicinal cannabis company, Helius Therapeutics, has been issued with the industry’s first GMP (Good Manufacturing Practice) certificate ...Read More